Skip to main content
. 2021 Aug 19;10(8):1002. doi: 10.3390/antibiotics10081002

Table 14.

In vitro antitumor activity of the compounds 109a109d toward A-549, HCT-116, Hep-G2 and MCF-7 cancer cell lines.

Compounds % Inhibitory Activity against Tumor Cell Lines at 300 μM
A-549 HCT-116 Hep-G2 MCF-7
109a 7.2 81.1 40.0 35.1
109b 38.3 65.5 60.8 49.4
109c 0.0 35.3 41.7 39.5
109d 48.8 49.9 62.4 59.6
Doxorubicin 84.1 ± 12.6 111.7 ± 20.5 63.6 ± 9.4 163.8 ± 10.1